CNTA
Centessa Pharmaceuticals
CNTA
CNTA
44 hedge funds and large institutions have $300M invested in Centessa Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
14% less capital invested
Capital invested by funds: $350M → $300M (-$49.8M)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Holders
44
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$9.85M | |
| 3 | +$2.81M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$975K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$503K |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$4.57M | |
| 3 | -$3.84M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$723K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$703K |